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Autism spectrum disorder (ASD) is characterized by a broad spectrum of behavioral deficits
of unknown etiology. ASD associated mutations implicate numerous neurological pathways
including a common association with the neurexin trans-synaptic connexus (NTSC) which
regulates neuronal cell-adhesion, neuronal circuitry, and neurotransmission. Comparable
DNA lesions affecting the NTSC, however, associate with a diversity of behavioral deficits
within and without the autism spectrum including a very strong association with Tourette
syndrome.The NTSC is comprised of numerous post-synaptic ligands competing for trans-
synaptic connection with one of the many different neurexin receptors yet no apparent
association exists between specific NTSC molecules/complexes and specific behavioral
deficits.Together these findings indicate a fundamental role for NTSC-balance in stabilizing
pre-behavioral control. Further molecular and clinical characterization and stratification of
ASD and TS on the basis of NTSC status will help elucidate the molecular basis of behav-
ior – and define how the NTSC functions in combination with other molecular determinates
to strengthen behavioral control and specify behavioral deficits.
Keywords: neurexin, NLGN, LRRTM, CBLN, GRID, LRRN,Autism,Tourette
INTRODUCTION
Autism presents within a broad group of neurodevelopmental
disabilities known as autism spectrum disorders (ASDs). ASDs
are characterized by impaired social interaction and communi-
cation and by restricted interests and repetitive behaviors with
high heritability estimates. Over 70% of individuals with autism
present with intellectual disability (ID) and ~25% with epilepsy
indicating overlapping etiologies in addition to secondary mol-
ecular determinates of behavior (Baird et al., 2006). There is
currently no reliable biomarker, pathology, anatomical finding,
or neuroimaging correlate that is specific for or predictive of ASD
(Lord et al., 2000; Bauman and Kemper, 2005; Courchesne et al.,
2007; Anagnostou and Taylor, 2011). Furthermore, precious lit-
tle has been established regarding the precise neurological basis
of ASD with many brain regions and circuits implicated (Bau-
man and Kemper, 2005; Courchesne et al., 2007; Amaral et al.,
2008; Anagnostou and Taylor, 2011). Several competing hypothe-
ses have been proposed to account for core behavioral deficits and
ancillary symptomatic domains in ASD, but none have been widely
accepted (Zoghbi, 2003; Belmonte et al., 2004; Courchesne et al.,
2007; Geschwind and Levitt, 2007; Rubenstein, 2010). Genomic
analyses indicate extreme genetic heterogeneity in ASD with a
conservative estimation of between 380 and 820 loci implicated
(Abrahams and Geschwind, 2008; O’Roak et al., 2012; Cristino
et al., 2013), where many of the loci are associated with over-
lapping biological pathways (O’Roak et al., 2012; Cristino et al.,
2013; Kenny et al., 2013; Yadav et al., 2013). Pathway overlap
also extends to neuropsychiatric disorders with behavioral profiles
outside the autism spectrum. In this respect, the neurexin trans-
synaptic connexus (NTSC) (Clarke et al., 2012), which regulates
development and maintenance of neuronal circuitry and neuro-
transmission is of particular relevance given its high mutation rate
in ASD and other neuropsychiatric disorders (Clarke et al., 2012;
O’Roak et al., 2012; Cristino et al., 2013; Kenny et al., 2013; Yadav
et al., 2013).
Global genomic studies have identified numerous genes/variants
and pathways implicated in the behavioral deficits associated with
ASD. Cristino et al. (2013) used copy number variations (CNV)
and SNP variant analyses to define 13 distinct protein modules
involved in ASD including the NTSC. In addition, O’Roak et al.
(2012) found high-density of mutations in the β-catenin and
p53 signaling pathways consistent with the influence of both de
novo and extremely rare inherited single nucleotide variations
(SNVs) and CNVs contributing to the overall genetic risk. The
wnt/β-catenin and Notch signaling pathways in neuronal devel-
opment are also implicated commensurate with the importance
of neuronal circuitry/boundaries and neurotransmission during
development as intersecting determinates for ASD (Griswold et al.,
2012; Kenny et al., 2013).
The neurexins (NRXNs) are one of the gene families most com-
monly mutated in ASD (Missler et al., 2003; Belloso et al., 2007;
Gauthier et al., 2011; Clarke et al., 2012; Vaags et al., 2012). NRXNs
are single-pass transmembrane proteins concentrated on the pre-
synaptic side of the synapse which facilitate neuronal cell-adhesion
through the formation of NRXN trans-synaptic cell-adhesion
complexes which together comprise the NTSC (Laurén et al., 2003;
Missler et al., 2003; Chen et al., 2006; Ko et al., 2009; Linhoff
et al., 2009; Wright and Washbourne, 2011; Clarke et al., 2012).
The extracellular domain of pre-synaptic NRXNs binds to one of
a range of post-synaptic ligands including neuroligins (NLGNs),
Frontiers in Human Neuroscience www.frontiersin.org February 2014 | Volume 8 | Article 52 | 1
Clarke and Eapen Balanced NTSC in behavioral control
FIGURE 1 | NTSC model for ASD andTourette Syndrome (Clarke et al.,
2012) implicates the full complement of known neurexin (NRXN –
green) trans-synaptic cell-adhesion ligand gene families through
multiple means of enquiry including the Neuroligin (NLGN – orange);
Leucine-rich repeat transmembrane protein (LRRTM – brown);
Cerebellin precursor (CBLN – grey); and glutamate receptor delta
(GluD/GRID – red) gene families. The pre-synaptic NRXNs form
trans-synaptic complexes with post-synaptic ligands NLGNs, LRRTMs, and
CBLNs-GRIDs in the formation and/or maintenance of neuronal circuitry
within the brain. Vertical arrows indicate putative pathogenic dose effects.
Neurexin isoforms with (+) and without (−) the 30 amino acid insert at
splice site 4 (IS4) dictate the different/competitive binding of NRXNs
between ligands. Co-morbidities listed are those associated with the TS
translocations and CNVs affecting the respective genes (Clarke et al., 2012).
leucine-rich repeat transmembrane proteins (LRRTMs), or cere-
bellin precursor (CBLN) glutamate receptor delta (Glu/GRID)
complexes (Figure 1) (Missler et al., 2003; Varoqueaux et al., 2006;
Ko et al., 2009; Linhoff et al., 2009; Mondin et al., 2011; Wright
and Washbourne, 2011; Clarke et al., 2012; Yasumura et al., 2012).
Together the three alpha-NRXNs 1–3 are essential for survival and
have a pivotal role in neurodevelopment and synaptic transmis-
sion where their roles partially overlap (Missler et al., 2003) and
all have been implicated in ASD (Missler et al., 2003; Belloso et al.,
2007; Wang et al., 2009; Sousa et al., 2010; Gauthier et al., 2011;
Clarke et al., 2012; Vaags et al., 2012; Cristino et al., 2013; Jones
et al., 2013; Kenny et al., 2013; Yadav et al., 2013). However, spe-
cific NTSC components do not associate with specific behavioral
deficits in ASD. Moreover, many of the same NTSC gene families
are found associated with other neuropsychiatric disorders outside
the autism spectrum including Tourette syndrome (TS), Asperger
syndrome, schizophrenia, and ID (Clarke et al., 2012). Neuroligin
4X (NLGN4X) is just one of the many NTSC single gene over-
laps between TS, ASD, and ID. The first, a NLGN4X truncation
mutation,was identified in a family comprising two affected broth-
ers, one with autism and ID and the other with ASD–Asperger
syndrome and normal intelligence (Jamain et al., 2003). Subse-
quently, a different NLGN4X truncating mutation was identified
in a multigenerational pedigree with 13 affected males with either
non-syndromic ID (10 individuals), ID with ASD, or ASD without
ID (Laumonnier et al., 2004). In 2008, another familial NLGN4X
truncating mutation was identified in two brothers with TS/motor
tic, one with ASD and the other with attention deficit/hyperactivity
disorder (ADHD) and a mother carrier with a learning disorder,
anxiety, and depression (Lawson-Yuen et al., 2008). This latter
NTSC association with TS and ADHD was just the first of many
such associations which have emerged since between the NTSC
and the divergent behavioral profiles of ASD and TS (Clarke et al.,
2012).
Tourette syndrome (TS) is characterized by motor and vocal
tics, with a pre-pubertal age of onset, a waxing and waning course,
and improvement in symptoms in adulthood (Eapen and Crncec,
2009). Clinical and epidemiological studies point to a very high
incidence of other childhood onset behavioral and developmental
disorders including up to 60% with ADHD and up to 50% with
obsessive–compulsive disorder (OCD). It has long been suggested
that chronic tics and OCD within TS families are likely mani-
festations of the same underlying genetic etiology with gender-
dependent differences in expression leading to male members of
the family exhibiting more tic behaviors and the female members
exhibiting OCD (Eapen et al., 1993). Furthermore, recent SNP
association data suggests that OCD in the presence of TS/Chronic
tics may have different underlying genetic susceptibility compared
to OCD alone (Eapen et al., 1993).
In the fore mentioned affected families the different behav-
ioral profiles appear to converge around the haploinsufficiency
of NLGN4X as the common molecular deficit. The mutation,
deletion, disruption and duplication of other NTSC compo-
nents are also relatively common in ASD and consistent with
dose effects (Sousa et al., 2010; Gilman et al., 2011; Sakai et al.,
2011; Voineagu et al., 2011; O’Roak et al., 2012; Cristino et al.,
2013). Association studies also show that many of the rare
variants associated with ASD occur within NTSC genes includ-
ing NRXN1-3, NRXN4/CNTNAP2, NLGN1, NLGN3, NLGN4X,
NLGN4Y, LRRTM1, LRRTM2, GRID1 (Sudhof, 2008; Sousa et al.,
2010; Gilman et al., 2011; Sakai et al., 2011; Voineagu et al., 2011;
Clarke et al., 2012; O’Roak et al., 2012; Cristino et al., 2013)
and genes encoding NTSC interacting proteins like SHANK1-3
(Cardno and Gottesman, 2000; O’Roak et al., 2011). Moreover,
recent network analyses indicate synaptic transmission as the
major protein hub within the ASD network and the only pro-
tein module with interactions with all other 12 major network
modules including cell–cell adhesion (Cristino et al., 2013).
The recent identification of GRID1 associating with ASD
(Cristino et al., 2013) and CBLN1 associating with autistic-like
traits (Jones et al., 2013) extends the association between the NTSC
and ASD and the molecular convergence between TS and ASD.
GRID1 is an inter-synaptic ligand of the post-synaptic transmem-
brane protein CBLN2 found associated with TS (Clarke et al.,
2012), that forms the tripartite NRXN–GRID1–CBLN2 trans-
synaptic cell-adhesion complex (Matsuda and Yuzaki, 2011; Clarke
et al., 2012). In fact all of the gene families encoding NTSC com-
plexes, with the exception of the GRIDs, have been implicated in
TS including the NRXN,NLGN, LRRTM, and CBLN gene families
(Petek et al., 2001; Verkerk et al., 2003; Belloso et al., 2007; Lawson-
Yuen et al., 2008; Sundaram et al., 2010; Patel et al., 2011; Clarke
et al., 2012; Fernandez et al., 2012). Of the 11 novel TS gene dis-
ruptions, exonic deletions, and truncations reported to date that
are either recurrent or familial, a total of 9 are associated with 1 of
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the 20 gene families encoding the NTSC [p= 5.5E – 26 (T -test)]
(Petek et al., 2001; Verkerk et al., 2003; Belloso et al., 2007; Lawson-
Yuen et al., 2008; Ercan-Sencicek et al., 2010; Sundaram et al., 2010;
Patel et al., 2011; Clarke et al., 2012; Fernandez et al., 2012). As such,
the NTSC emerges as a primary determinate for TS (Clarke et al.,
2012) and thus by inference a primary determinate for that subset
of ASDs with NTSC association. Moreover, as is the case with ASD
the bulk of the NTSC mutations associated with TS to date are
consistent with dose effects with no apparent correlation between
any of the different receptors or ligands of the NTSC and specific
behavioral deficits in or between ASD and TS. Rather, the stoichio-
metric balance between the various competitive NTSC ligands and
receptors appears to play a protective gate-keeping role in behav-
ioral control as outlined in the pathogenetic model (Figure 1)
(Clarke et al., 2012).
The striking molecular convergence between TS and ASD at the
NTSC may help explain epidemiological features shared between
TS and ASD but not the behavioral divergence. TS and ASD are
both conditions that begin during childhood (~1% of children
affected) and both are more common in males than in females.
The inheritance patterns of TS are also comparable with that of
ASD. TS twin studies suggest a monozygotic to dizygotic concor-
dance of up to 77% and family studies consistently demonstrate
up to a 100-fold increase in the rates of TS in first-degree rela-
tives comparable with the high heritability of the ASDs (O’Rourke
et al., 2009). ASD is also over represented in TS, and clinically,
symptoms such as obsessions, compulsive behaviors, involuntary
movements (tics in TS and stereotypies in ASD), poor speech con-
trol, and echolalia are common in both conditions. Furthermore,
the literature suggests that around 20–40% of individuals with
ASD experience tics and over 50% of individuals with ID and ASD
also exhibit tics (Kadesjo and Gillberg,2000; O’Rourke et al., 2009).
Such overlap in symptoms presumably stems from the interre-
lated neuronal circuitry involved in the final common pathways
of behavioral expression (Eapen et al., 2013). However, the diver-
gent behaviors seen in the two conditions with motor and vocal
tics in TS, and impaired social interaction and communication
and restricted interests seen in ASD presumably relate to sec-
ondary/auxillary molecular and/or environmental determinants
impacting neuronal circuitry development/maintenance and/or
transmission.
In addition to the prevalence of NTSC dose effects in ASD and
TS, the competition for connections between NRXNs and their
trans-synaptic ligands (Figure 1) further supports the require-
ment for NTSC-balance in behavioral control. This in turn pro-
vides insight into the behavioral role of molecules linked to the
NTSC. For example, the SHANK proteins which function from
the post-synaptic side of the NTSC are also commonly asso-
ciated with ASD. The SHANK proteins mediate attachment of
the intracellular PDZ-binding domains of NTSC receptor/ligand
complexes, including NRXN–NLGN and NRXN–LRRTM (Clarke
et al., 2012), to the local actin-based cytoskeleton within den-
dritic spines. Furthermore, in Purkinje cells, the post-synaptic
clustering of SHANK2 with GRID2 appears dependent on the
integrity of the tripartite NRXN–GRID2–CBLN1 trans-synaptic
complex (Joo et al., 2011; Matsuda and Yuzaki, 2011; Jones et al.,
2013). Another TS/ASD candidate gene of related interest to the
SHANKs is synapse-associated protein 97 (SAP97 ) which encodes
a scaffold-like protein located on the post-synaptic side of the
synapse. Linkage analysis of a large TS pedigree identified the
strongest linkage marker (D3S1311) within SAP97 (Verkerk et al.,
2006) and a male individual with TS and ASD has been iden-
tified with duplication of the SAP97 gene locus (unpublished
data), whereas micro-deletion of 3q inclusive of SAP97 is com-
monly associated with schizophrenia. SAP family proteins bind
directly to NTSC complexes and to NMDA, AMP, and kainate
receptors at the synapse (Rumbaugh et al., 2003) and membrane-
diffusing AMPARs can be rapidly trapped at SAP90/PSD95 scaf-
folds assembled at nascent NTSC (NRXN–NLGN) adhesions
(Mondin et al., 2011). Moreover, the TS candidate ZnT3 (Clarke
et al., 2012) – a synaptic zinc transporter which controls concen-
trations of Zn2+ within post-synaptic vesicles – is of particular
interest here given the concentration of Zn2+ ions within the
post-synaptic density (PSD) is known to affect the recruitment
of scaffolding proteins like SHANK2 and SHANK3 (Grabrucker
et al., 2011).
NTSC RELATION TO NEUROLOGICAL PATHOLOGIES IN ASD
AND TS
The neuronal cell-adhesion complexes of the NTSC promote
synapse formation and/or maintenance bi-directionally in the
glutamatergic and GABA-ergic nervous system. As such, NTSC-
imbalance will translate as an imbalance in neuronal connectivity
through changes in synapse patterning and transmission (Missler
et al., 2003; Varoqueaux et al., 2006; Ko et al., 2009; Linhoff et al.,
2009; Clarke et al., 2012). Loss of CBLN2, as reported in TS (Clarke
et al., 2012), is associated with reduced mediation of inhibitory
synaptogenesis (Yasumura et al., 2012). This however, appears in
opposition with the reduced number of excitatory synapses asso-
ciated with the downregulation of NLGN4X or the LRRTMs in
TS (Figure 1) (Ko et al., 2009; Wright and Washbourne, 2011),
albeit the recurrent loss/disruption of NRXN1 in TS and ASD
infers loss of both excitatory and inhibitory synaptic connections.
Together these findings further reinforce the importance of a bal-
anced NTSC repertoire rather than “specific complexes” as the
basis of NTSC related behavioral disorders.
Synaptic homeostasis depends on the balance between the
strength of excitation, inhibition, and the intrinsic excitability of
the neuronal circuitry. Evidence suggests that the balance between
excitation and inhibition is tightly regulated with even small
changes affecting neuronal firing (Atallah and Scanziani, 2009;
Pouille et al., 2009). When this balance is perturbed, mechanisms
come into play to restore synaptic homeostasis by modifying the
balance between excitatory and inhibitory inputs or the applica-
tion of intrinsic mechanisms to modify the balance of inward
and outward voltage-dependent current (Gainey et al., 2009).
Synapses are formed even when αNRXN l is deleted from the
mouse genome, however, this compromises synaptic transmission
(Missler et al., 2003). The pre-synaptic co-assembly of Ca2+ chan-
nels with the secretory apparatus is a prerequisite for the release
of neurotransmitters like glutamate and this channel function is
impaired in αNRXN1 knockout mice with consequent reductions
in neurotransmitter release (Missler et al., 2003). The NTSC trans-
synaptic connections NRXN–NLGN and NRXN–LRRTM are both
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sensitive to extracellular Ca2+ concentrations which appear to
trigger post-synaptic differentiation and control the balance of
inhibitory GABA-ergic and excitatory glutamatergic inputs. Gluta-
mate, the main excitatory neurotransmitter in the vertebrate brain,
has a major role in cortico-striatal-thalamo-cortical circuits and
several lines of evidence support the role of glutamate in TS includ-
ing: the TS association of glutamate receptors that are localized in
the cellular membranes of both neurons and glia; the recognized
extensive interaction between glutamate and dopamine systems;
results of familial genetic studies; and data from neurochemi-
cal analyses of post-mortem brain samples (Felling and Singer,
2011; Clarke et al., 2012). Interestingly, LRRTM1 null mice have
altered distribution of the excitatory pre-synaptic vesicular gluta-
mate transporter VGLUT1 (Ko et al., 2009; Linhoff et al., 2009).
Furthermore, loss of excitatory synaptic connections results in a
hypo-glutamatergic state that is consistent with a loss in the synap-
tic weight, which is an all important factor for the circuit strength
required in language development (Matsuda and Yuzaki, 2011).
NEURAL CIRCUITRY AS A FUNCTION OF SYNAPTIC PRUNING
AND BOUNDARY FORMATION
Synaptic pruning plays an important role during maturation of the
brain by limiting neural circuitry, and neural circuitry within spe-
cific brain regions is implicated in behavioral control. As such the
integrity of neural/brain boundaries may be a factor in neuropsy-
chiatric disorders. In this respect, it is most interesting to note that
both ASD and TS have been associated with leucine-rich repeat
neuronal (LRRN) type I transmembrane protein genes. LRRN3 is
localized within the genomic region most commonly duplicated
in ASD (Kroisel et al., 2001; Maestrini et al., 2010; Pagnamenta
et al., 2010). LRRN3 is also nested in an antisense orientation
within the IMMP2L gene recurrently disrupted in TS and ASD
(Clarke et al., 2012). Moreover, the nearest gene relation to LRRN3,
LRRN1, has been duplicated in ASD (Davis et al., 2009). These
associations suggest increased dose of LRRN1 and LRRN3 maybe
pathogenic for ASD and TS. Little is known about the function of
LRRN3, however, LRRN1 is known to have a key role in regional
boundary formation within the brain (Chen et al., 2006; Tossell
et al., 2011). Studies in the developing chick demonstrate that the
midbrain–hindbrain boundary (MHB) is established through the
down regulation of Lrrn1 by Fgf8 on the posterior side of the future
boundary (Tossell et al., 2011), thereby creating a differential cel-
lular affinity between the two compartments likely to involve an
as yet unspecified extracellular binding partner for Lrrn1. Lrrn1
in turn regulates the expression of the Lunatic Fringe gene which
modulates Notch signaling to complete MHB formation. Over-
expression of Lrrn1 disrupts the MHB with mixing of cells between
compartments (Tossell et al., 2011). For further insight into this
association see (Clarke et al., 2012).
AUXILLARY MOLECULAR AND ENVIRONMENTAL
DETERMINANTS SPECIFY BEHAVIORAL DEFICITS
Imbalance in the NTSC appears to be sufficient for but not
definitive in specifying the nature of behavioral pathogenesis.
Moreover, recent evidence suggests that numerous gene variants
combine with environmental and physiological factors to spec-
ify behavioral deficits. For example, the sex-specific imprinting of
NRXN4/CNTNAP2,CTNNA3, and LRRTM1 is known to alter the
expression of these genes and their parent-of-origin phenotypic
inheritance patterns (Oudejans et al., 2004; Francks et al., 2007).
Thus, a particular phenotypic co-morbidity may present based
on the type and level of involvement of the different NTSC neuro-
transmitter pathways in combination with secondary determinates
that mediate or modulate NTSC pathways during neurodevelop-
ment whereas an early environmental insult could specify an alter-
nate behavioral deficit/neural outcome (Herbert, 2010) including
effects associated with prematurity, perinatal trauma, hypoxia,
injury oxidative stress, inflammations, infections and autoimmu-
nity, neural and psychosocial stressors, gender effects, etc. (Eapen,
2011). Gender-specific differences exist in the topographic seg-
regation and functionality of GABA-A systems in the substantia
nigra, moreover, circulating testosterone is essential for the devel-
opment of the substantia nigra region in the neonatal period and
to a lesser extent for final maturation in the peripubertal period
(Veliskova and Moshe, 2001). In this regard, a role for testosterone
has been suggested in the extreme male brain hypothesis in ASD
(Baron-Cohen, 2002). Similar mechanisms may affect the TS genes
leading to gender-dependent difference in phenotypic expression –
with male members of TS families exhibiting more tic behaviors
and female members more OCD (Eapen et al., 1993, 1997). Thus,
an NTSC related imbalance that impacts development of different
neuronal regions and circuitry maybe further specified by sec-
ondary genetic and/or environmental events (Eapen et al., 2014).
The penetrance of the different co-morbidities may also be related
to gender, gene dose effects, or the timing of events when different
brain regions are being formed, thus resulting in different clinical
phenotypes (Eapen et al., 2013).
CONCLUSION
The NTSC provides an invaluable window into the molecular basis
of behavior. The role of NTSC-balance as a gate keeper of behav-
ioral control provides a firm basis for more in depth molecular
and clinical characterization and stratification of behavioral dis-
orders. To this end, NTSC’s common association with ASD and
Tourette syndrome provides the ideal starting point for molecular
and clinical comparisons between select ASD and TS families.
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